- Home
- GRNQ vs CYCN Comparison
GRNQ vs CYCN Comparison
Compare GRNQ & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRNQ
- CYCN
- Stock Information
- Founded
- GRNQ 2013
- CYCN 2018
- Country
- GRNQ Malaysia
- CYCN United States
- Employees
- GRNQ N/A
- CYCN N/A
- Industry
- GRNQ EDP Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- GRNQ Technology
- CYCN Health Care
- Exchange
- GRNQ Nasdaq
- CYCN Nasdaq
- Market Cap
- GRNQ 12.8M
- CYCN 6.5M
- IPO Year
- GRNQ 2018
- CYCN N/A
- Fundamental
- Price
- GRNQ $2.42
- CYCN $3.62
- Analyst Decision
- GRNQ
- CYCN
- Analyst Count
- GRNQ 0
- CYCN 0
- Target Price
- GRNQ N/A
- CYCN N/A
- AVG Volume (30 Days)
- GRNQ 97.1K
- CYCN 32.3K
- Earning Date
- GRNQ 08-12-2025
- CYCN 08-06-2025
- Dividend Yield
- GRNQ N/A
- CYCN N/A
- EPS Growth
- GRNQ N/A
- CYCN N/A
- EPS
- GRNQ N/A
- CYCN N/A
- Revenue
- GRNQ $3,190,761.00
- CYCN $2,081,000.00
- Revenue This Year
- GRNQ N/A
- CYCN N/A
- Revenue Next Year
- GRNQ N/A
- CYCN N/A
- P/E Ratio
- GRNQ N/A
- CYCN N/A
- Revenue Growth
- GRNQ N/A
- CYCN N/A
- 52 Week Low
- GRNQ $0.80
- CYCN $1.27
- 52 Week High
- GRNQ $2.49
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- GRNQ 82.35
- CYCN 63.94
- Support Level
- GRNQ $1.78
- CYCN $2.95
- Resistance Level
- GRNQ $1.92
- CYCN $3.73
- Average True Range (ATR)
- GRNQ 0.17
- CYCN 0.33
- MACD
- GRNQ 0.05
- CYCN 0.06
- Stochastic Oscillator
- GRNQ 93.14
- CYCN 89.22
About GRNQ Greenpro Capital Corp.
Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.